Tiny worms could be key to solving Type 1 diabetes and other autoimmune ailments
There is a new weapon in the fight against autoimmune diseases such as Type 1 diabetes, rheumatoid arthritis, Crohn’s disease and lupus, the common trait of which is an immune system that attacks its own organs and tissues.
William Gause, an immunologist at Rutgers New Jersey Medical School, is among those leading the charge against these diseases by studying how the human body reacts to worms. The worms Gause studies, or helminths as biologists call them, are small parasites that live in human intestines, especially in the developing world.
According to an article in Nature Reviews Immunology by Gause and colleagues from the National Institutes of Health and the University of Edinburgh, the worms’ presence through millennia of human evolution likely has led to an immune response called type 2 immunity. This includes immune regulatory pathways that help control the inflammation that can contribute to autoimmune diseases.
The immune reaction, the researchers say, appears to have developed as a way to rapidly repair wounds caused by these invaders as they move through the body. In fact, components of the type 2 immune response may someday be used to enhance the wound healing process. Additionally, this response triggers regulatory networks that block harmful immune responses, or inflammation, that otherwise would exacerbate the tissue injury.
“What we would like to do now is harness components of the type 2 immune response to target the control of harmful inflammation that can lead to autoimmune diseases like diabetes and inflammatory bowel disease,” Gause says. He adds that inflammatory responses also have been linked to other diseases, including cardiovascular disease and metabolic disorders, and even to allergic reactions and fibrosis that may result when titanium shavings that flake away from artificial joints settle in the body. “Finding new ways to stimulate these regulatory components of the type 2 immune response may provide us with a new set of tools to target the control of harmful inflammatory responses now associated with this wide array of different diseases.”
For now, live helminths or helminth byproducts may be introduced into the body on a short-term basis to train compromised immune systems. A 2012 study by a Gause-led team found that the introduction of helminths for two weeks caused the immune systems of mice to produce cytokines, or signaling molecules, which gave them lasting protection against Type 1 diabetes.
That finding mirrors human experience in the developing world where helminth infection is endemic, but the incidence of autoimmune diseases such as Type 1 diabetes is extremely low.
“There is a growing body of evidence to support the hygiene hypothesis, which suggests that decreased exposure to microbes and helminths in industrialized countries may impair the development of immune regulatory networks that would otherwise control harmful inflammatory responses,” Gause says.
The Latest on: Parasites as Potential Disease Fighters
- NeuBase Therapeutics Hosting Key Opinion Leader Meeting on Huntington's Disease and PATrOL™-Enabled Therapy on September 16th Nasdaq: NBSEon September 9, 2019 at 6:51 am
NeuBase' or the 'Company'), a biotechnology company developing next-generation antisense therapies to address genetic diseases, today announced that it will host a Key Opinion Leader (KOL ...
- Potential MS Therapy Promotes Myelin Repair in Miceon September 9, 2019 at 6:35 am
Scientists at Oregon Health & Science University (OHSU) have developed a compound that promotes repair of the nerve cell-protective myelin sheath that is damaged in diseases such as ... hyaluronidase ...
- Neurotrope Announces Top-line Results From Confirmatory Phase 2 Study of Bryostatin-1 in Moderate to Severe Alzheimer's Diseaseon September 9, 2019 at 6:27 am
In addition to the Company's Phase 2 trial of Bryostatin-1 in advanced AD, Neurotrope has also conducted preclinical studies of Bryostatin-1 as a potential treatment for rare diseases and brain ...
- NeuBase Therapeutics Hosting Key Opinion Leader Meeting on Huntington's Disease and PATrOL™-Enabled Therapy on September 16thon September 9, 2019 at 5:48 am
09, 2019 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (NASDAQ:NBSE) ("NeuBase" or the "Company"), a biotechnology company developing next-generation antisense therapies to address genetic diseases .
- Ageing as a risk factor for neurodegenerative diseaseon September 9, 2019 at 5:42 am
The central biological mechanisms of ageing and their potential as targets of novel therapies for neurodegenerative diseases are also discussed, with potential therapies including NAD + precursors, ...
- Intercept Appoints Lisa DeFrancesco as Vice President, Investor Relationson September 9, 2019 at 5:00 am
NEW YORK, Sep 09, 2019 (GLOBE NEWSWIRE via COMTEX) -- Intercept Pharmaceuticals, Inc. ICPT, -2.62%, a biopharmaceutical company focused on the development and commercialization of novel therapeutics ...
- AIM ImmunoTech Inc. Announces its Name Change is Complete, Its New Website is Up and the Company Now Trades as Ticker Symbol 'AIM'on September 9, 2019 at 4:45 am
The immuno-tech company, which is focused on the research and development of immunological agents to treat multiple types of cancers and immune-deficiency diseases -such as myalgic ... conducted ...
- ‘Asexual’ Chagas Parasite Found to Sexually Reproduceon September 9, 2019 at 12:22 am
In order to study how the disease spreads, as well as find potential new treatments, scientists at the University of Glasgow knew it was important to understand how the parasite reproduced. Sex in ...
- CDC warns against vaping after series of lung-disease caseson September 8, 2019 at 10:46 pm
Hundreds of people across the country have been sickened by a severe lung disease linked to e-cigarette use. The Centers for Disease Control and Prevention (CDC) warns the public not to use ...
- Turning to Parasites as Potential Disease Fighterson June 30, 2019 at 5:00 pm
There is a new weapon in the fight against autoimmune diseases such as Type 1 diabetes, rheumatoid arthritis, Crohns disease and lupus, the common trait of which is an immune system that attacks its ...
via Google News and Bing News